|
受注:045-509-1970 |
技術サポート:tech@selleck.co.jp 平日9:00〜18:00 1営業日以内にご連絡を差し上げます |
|
Synonyms | BIBR 953 | Storage (From the date of receipt) |
3 years -20°C powder 1 years -80°C in solvent |
| 化学式 | C25H25N7O3 |
|||
| 分子量 | 471.51 | CAS No. | 211914-51-1 | |
| Solubility (25°C)* | 体外 | DMSO | 0.5 mg/mL (1.06 mM) | |
| Ethanol | 0.01 mg/mL (0.02 mM) | |||
| Water | Insoluble | |||
|
* <1 mg/ml means slightly soluble or insoluble. * Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
||||
| 製品説明 | Dabigatranは、強力な非ペプチド・トロンビン阻害剤で、IC50が9.3 nMです。 |
|---|---|
| in vitro | BIBR 953 is a very potent anticoagulant. This compound shows that the terminal phenyl can be substituted by the more hydrophilic 2-pyridyl group without substantial loss of activity. It inhibits thrombin, plasmin, factor Xa, trypsin, tPA and activated protein C with Ki of 4.5 nM, 1.7 μM, 3.8 μM, 50 nM, 45 μM and 20 μM, respectively. This chemical specifically and reversibly inhibits thrombin. |
| in vivo | BIBR 953 exhibits the most favorable activity profile following i.v. administration to rats. The bioavailability of this compound after p.o. administration of dabigatran etexilate is 7.2%. It is predominantly excreted in the feces after p.o. treatment and in the urine after i.v. treatment. The mean terminal half-life of this chemical is approximately 8 hours. Its acylglucuronides accounts for 0.4% and 4% of the dose in urine after p.o. and i.v. dosing, respectively. |
| 特徴 | Dabigatran is a reversible, competitive, direct thrombin inhibitor. |
| キナーゼアッセイ | Measurement of thrombin inhibition | |
|---|---|---|
| The thrombin inhibitory effects (IC50) of Dabigatran is determined with a commercially available chromogenic assay. Human thrombin (0.042 U/mL) is preincubated for 10 minutes at 37 °C with 10 different dilutions (concentration range of 0.003 μM -100 μM) of this compound dissolved in DMSO or with DMSO as control. Upon addition of the preincubation mixture to the chromogenic substrate, tosyl-glycyl-prolyl-arginine-4-nitranilide acetate, nitraniline is cleaved by thrombin and the increase in absorbance at 405 nm, related to the free nitraniline, is measured in a spectrophotometer. By plotting the absorbance at 405 nm vs the concentration of this chemical, the concentration that induces a 50% thrombin inhibition (IC50) is calculated. All measurements are performed in duplicate, and the mean values of both determinations are represented. | ||
| 動物実験 | 動物モデル | Rats |
| 投薬量 | ||
| 投与方法 | Administered via i.v. | |
|

Data from [Thromb Res, 2014, 133 Suppl 1, S6-8]

, , J Thromb Thrombolysis, 2017, 44(2):216-222

Data from [Data independently produced by , , Sci Rep, 2016, 6:29387]
| Effects of Heparin and Bivalirudin on Thrombin-Induced Platelet Activation: Differential Modulation of PAR Signaling Drives Divergent Prothrombotic Responses [ Frontiers in Cardiovascular Medicine, September 29, 2021, 717835] | PubMed: 34660719 |
| Hemorrhagic Transformation After Large Cerebral Infarction in Rats Pretreated With Dabigatran or Warfarin [ Stroke, October 2017, 2865-2871] | PubMed: 37758192 |
| Hemostasis stimulates lymphangiogenesis through release and activation of VEGFC [ Blood, November 14, 2019, 1764-1775] | PubMed: 31562136 |
| A rapid pro-hemostatic approach to overcome direct oral anticoagulants [ Nature Medicine, July 25, 2016, 924-932] | PubMed: 27455511 |
| An engineered factor Va prevents bleeding induced by direct-acting oral anticoagulants by different mechanisms [ Blood Advances, August 11, 2020, 3716-3727] | PubMed: 32777068 |
| HemoDens: A global hemostasis analyzer for kinetic characterization of clot formation, retraction, and lysis [ Thromb Res, 2025, 255:109480] | PubMed: 40987075 |
| Real-Time Imaging of Platelet-Initiated Plasma Clot Formation and Lysis Unveils Distinct Impacts of Anticoagulants [ Thromb Haemost, 2025, 10.1055/a-2497-4213] | PubMed: 39788528 |
| Dabigatran Attenuates the Binding of Thrombin to Platelets-A Novel Mechanism of Action [ Thromb Haemost, 2024, 10.1055/a-2483-0107] | PubMed: 39586831 |
| Detection of direct oral anticoagulants with the diluted Russel's viper venom time [ Int J Lab Hematol, 2024, 10.1111/ijlh.14300] | PubMed: 38721750 |
| DPP4 inhibition impairs senohemostasis to improve plaque stability in atherosclerotic mice [ J Clin Invest, 2023, 133(12)e165933] | PubMed: 37097759 |
長期の保管のために-20°Cの下で製品を保ってください。
人間や獣医の診断であるか治療的な使用のためにでない。
各々の製品のための特定の保管と取扱い情報は、製品データシートの上で示されます。大部分のSelleck製品は、推薦された状況の下で安定です。製品は、推薦された保管温度と異なる温度で、時々出荷されます。長期の保管のために必要とされてそれと異なる温度で、多くの製品は、短期もので安定です。品質を維持するが、夜通しの積荷のために最も経済的な貯蔵状況を用いてあなたの送料を保存する状況の下に、製品が出荷されることを、我々は確実とします。製品の受領と同時に、製品データシートの上で貯蔵推薦に従ってください。